News About: Pharm. Industry
Sanofi set up clinical research and R&D unit in Korea.
For the first time in Korea following Singapore, a foreign multinational drug corporation, Sanofi-Aventis, has established "Clinical Research Unit" for the new drug R&D and the international clinical study management ...
Gleevec inventor from Novartis visits Korea.
Dr. Alex Matter, the developer of Gleevec and the chief researcher of Novartis tropical medicine institute will visit to "Bio camp" of Korea and deliver a lecture titled "new drug development in the third millennium ...
Bayer Korea to resume wholesale business under contract renewal.
Most of pharmaceutical companies are in trouble with the stronghold wholesalers and the associated wholesalers but Bayer Korea decided to continue wholesale business under an amicable relationship with wholesalers.
...
Janssen Korea to achieve 20 years of no accidents.
Janssen Korea has achieved "No Accidents" for 20 years in their factory operation, and firmly fixed its position as a production center in the pacific area of Johnson and Johnson pharmaceutical division by completing ...
Daewoong to appoint 16 associated wholesalers in metropolitan areas.
Daewoong announced on June 13 to appoint 16 associated wholesalers in 6 sectors of the East, West, South, North, Gyeonggi South and Gyeongin in the metropolitan areas.
A member of Daewoong said "We will have a regu...
Hanil and Japanese Nippon Chemiphar signed business tie-up
Hanil signed an agreement with Nippon Chemiphar on June 7 for the distribution of Ozagron, a CNS drug.
President Lee Dong-il of Hanil said "we could expand the market for Ozagron in combination with injectable Herb...
Novartis Korea conducted 29 multinational clinical studies.
About 29 multinational clinical studies were projected by Novartis Korea to conduct this year, which will be the top in number of the Koreas pharmaceutical industry, spending $30 million for 3 years financed by its he...
Sandoz looking at Korean OTC market.
Sandoz, a subsidiary of Novartis's OTC business, is now seeking for the OTC drug market in Korea.
Novartis Korea said that Sandoz, a Novartis affiliate for the OTC drug business, took over Hexal AG, the 2nd top OTC d...
Daiichi Korea's sales and profits declined.
Daiichi Korea reported the 15th fiscal year (April 1, 2004 to Mar. 31, 2005) financial statement covering 11.1 billion won of sales (3.24% up from the previous year period), 1,376 million won of operating income (36.7...
National Assembly debate on NHI drug price approval.
Rep. Kang Ki-jeong of Uri Party, a member of the National Assembly, Health and Welfare Committee, said on June 10 in the interpellation meeting that the NHI drug pricing policy should be ameliorated currently from the...
